GLP-1 SM 50mg Peptides
Advance your study with a peptide prepared for precision from the first opening to the final data point.
Primavora GLP-1 SM is a lyophilized research peptide supplied as a single-vial format with a total content of 50mg. This unflavored, laboratory-grade preparation is designed to support reliable reconstitution, consistent aliquoting, and accurate experimental planning across repeated runs.
- Each vial contains 50mg of GLP-1 SM, a laboratory peptide investigated in metabolic signaling research, including pathways related to glucose homeostasis, satiety mechanisms, and gastric motility dynamics.
Engineered for dependable handling, the lyophilized matrix is produced for uniformity and clean reconstitution in an appropriate research diluent. Researchers can expect a consistent visual profile for the cake, controlled particulate levels, and lot-specific documentation to support traceability. The sealed vial format helps maintain integrity during storage and routine laboratory workflows.
This preparation is suited to method development, assay calibration, and exploratory studies requiring reproducible concentrations. Careful lot control and measured fill support precise volumetric preparations, enabling clear lineage from stock solutions to working concentrations. For best stability, store under appropriate cold conditions and follow standard laboratory handling practices during reconstitution and aliquoting.
Why Primavora: Our peptides are produced in the USA and tested by HPLC and mass spectrometry to verify identity and assess purity. Each lot is documented, lot-coded, and released only after stringent quality review. From sourcing to final packaging, we maintain controlled conditions intended to protect consistency. Certificates of Analysis are available to support your internal quality requirements.
Ingredients: GLP-1 SM.
For laboratory research use only. Not for human consumption or injection. Not for clinical, therapeutic, diagnostic, or veterinary use. Handle using appropriate laboratory safety procedures.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-1 SM?
GLP-1 SM appears to be a supplier-specific GLP-1-based research product. The 'SM' label is not a standardized pharmacologic name, so a careful description should avoid guessing the exact analog unless the sequence or active ingredient is shown on the specification sheet. It is best framed as a GLP-1-pathway research compound for laboratory use only.
What is GLP-1 SM typically studied for?
GLP-1-based compounds are generally studied for appetite regulation, glucose handling, insulin-related signaling, and body-weight change in metabolic models. For this specific item, the strongest FAQ wording is to explain the GLP-1 research category while also telling users to confirm the exact analog on the lot documents.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Prima Vora are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
